|

Cardiac Amyloidosis Registry of University Hospital Leipzig

RECRUITINGSponsored by University of Leipzig
Actively Recruiting
SponsorUniversity of Leipzig
Started2023-05-01
Est. completion2033-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06129656

Summary

This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Confirmed cardiac amyloidosis according to current standards

Exclusion Criteria:

* refusal to participate

Conditions2

Cardiac AmyloidosisHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.